Introduction
Francisella tularensis is best known as the zoonotic, highly infectious etiologic agent of the human disease, tularemia. There are three recognized species in the genus Francisella: F. tularensis, F. novicida, and F. philomiragia. All three species can cause human infections, although F. novicida and F. philomiragia rarely do. Disease caused by F. tularensis can be mild but it usually is acute, severe and febrile; infection with a common North American strain can be life threatening.
Phylogeny
Analysis of the 16S rRNA of Francisella species places them in the λ-subclass of the Proteobacteria (Forsman, 1994). All of the Francisella are closely related (98.5 to 99.9% sequence identity in the 16S rDNA sequence) and form a group together with Wobachia persica (97.85 identity) (Forsman, 1994). Recently, two groups discovered endosymbionts of the tick species, Ornithodoros moubata (Noda, 1997) and Dermacantor andersoni (Niebylski, 1997) that could be placed in the Francisella...
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiterature Cited
Allen, W. P. 1962 Immunity against tularemia: passive protection of mice by transfer of immune tissues J. Exp. Med. 115 411–420
Ancuta, P., R. Pedron, R. Girard, G. Sandström, and Chaby. 1996 Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins Infect. Immun. 64 2041–2046
Anthony, L. S. D., and P. A. L. Kongshavn. 1987 Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance Microb. Path. 2 3–14
Anthony, L. S. D., E. Skamene, and P. A. L. Kongshavn. 1988 Influence of genetic background on host resistance to experimental murine tularemia Infect. Immun. 56 2089–2093
Anthony, L. S. D., E. Ghadirian, F. P. Nestel, and P. A. L. Kongshavn. 1989 The requirement for gamma interferon in resistance of mice to experimental tularemia Microb. Path. 7 421–428
Anthony, L. S. D., R. D. Burke, and F. E. Nano. 1991a Growth of Francisella spp. in rodent macrophages Infect. Immun. 59 3291–3296
Anthony, L. S. D., S. C. Cowley, M. Gu, W. W. S. Leung, and F. E. Nano. 1991b Transformation and allelic replacement in Francisella spp J. Gen. Microbiol. 137 2697–2703
Anthony, L. S. D., P. J. Morrissey, and F. E. Nano. 1992 Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism J. Immunol. 148 1829–1834
Anthony, L. S. D., K. E. Mdluli, S. C. Cowley, and F. E. Nano. 1994 Isolation of a Francisella tularensis mutant that is sensitive to serum and oxidative killing and is avirulent in mice: Correlatiion with the loss of MinD homologue expression FEMS Microbiol. Lett. 124 157–166
Baron, G. S., and F. E. Nano. 1998 MglA and MglB are required for the intramacrophage growth of Francisella novicida Mol. Microbiol. 29 247–259
Baron, G. S., and F. E. Nano. 1999a An erythromycin resistance cassette and mini-transposon for constructing transcriptional fusions to cat Gene 229 59–65
Baron, G. S., T. J. Reilley, and F. E. Nano. 1999b The respiratory burst inhibiting acid phosphatase AcpA is not essential for the intramacrophage growth and virulence of Francisella novicida FEMS Microbiol. Lett. 176 85–90
Berg, J. M., K. E. Mdluli, and F. E. Nano. 1992 Molecular cloning of the recA gene of Francisella novicida and the construction of recA mutants Infect. Immun. 60 690–693
Bernard, K., S. Tessier, J. Winstanley, D. Chang, and A. Borczyk. 1994 Early recognition of atypical Francisella tularensis strains lacking a cysteine J. Clin. Microbiol. 32 551–551
Blomley, D. J., and A. D. Pearson. 1972 Case of tularaemia in England Br. Med. J. 4 235–235
Brachman, P. S. 1969 Francisella tularensis in New England N. Engl. J. Med. 280 1296–1297
Buchanan, T. M., G. F. Brooks, and P. S. Brachman. 1971 The tularemia skin test. 325 skin tests in 210 persons: serologic correlation and review of the literature Ann. Int. Med. 74 336–343
Burke, D. S. 1977 Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia J. Infect. Dis. 135 55–60
Capellan, J., and I. W. Fong. 1993 Tularemia from a cat bite: case report and review of feline-associated tularemia Clin. Inf. Dis. 16 472–475
Chamberlain, R. E. 1965 Evaluation of live tularemia vaccine prepared in chemically defined medium Appl. Microbiol. 13 232–235
Cherwonogrodzky, J. W., M. H. Knodel, and M. R. Spence. 1994 Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium Vaccine 12 773–775
Claflin, J. W., and C. L. Larson. 1972 Infection-immunity in tularemia: specificity of cellular immunity Infect. Immun. 5 311–318
Clarridge, J. E. 3rd, T. J. Raich, A. Sjosted, G. Sandstrom, R. O. Darouiche, R. M. Shawar, P. R. Georghiou, C. Osting, and L. Vo. 1995 Characterization of two unusual clinically significant Francisella strains J. Clin. Microbiol. 34 1995–2000
Conlan, J. W., and R. J. North. 1992 Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes Infect. Immun. 60 5164–5171
Conlan, J. W., A. Sjöstedt, and R. J. North. 1994 CD4+ and CD8+ T-cell-dependent and-independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice Infect. Immun. 62 5603–5607
Cowley, S. C., S. V. Myltseva, and F. E. Nano. 1996 Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production Mol. Microbiol. 20 867–874
Culkin, S. J., T. Rhinehart-Jones, and K. L. Elkins. 1997 A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS J. Immunol. 158 3277–3284
Dahlstrand, S., O. Ringertz, and B. Zetterberg. 1971 Airborne tularemia in Sweden Scand. J. Infect. Dis. 3 7–16
Eigelsbach, H. T., Braun, W., and Herring, R. D. 1951 Studies on the variation of Bacterium tularense J. Bact. 61 557–569
Eigelsbach, H. T., and C. M. Downs. 1961 Prophylactic effectiveness of live and killed tularemia vaccines J. Immunol. 87 415–425
Eigelsbach, H. T., J. J. Tulis, M. H. McGavran, and J. D. White. 1962 Live tularemia vaccine. I. Host-parasite relationship in monkeys vaccinated intracutaneously or aerogenically J. Bacteriol. 84 1020–1027
Elkins, K. L., D. A. Leiby, R. K. Winegar, C. A. Nacy, and A. H. Fortier. 1992a Rapid generation of specific protective immunity to Francisella tularensis Infect. Immun. 60 4571–4577
Elkins, K. L., R. K. Winegar, C. A. Nacy, and A. H. Fortier. 1992b Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity Microb. Path. 13 417–421
Elkins, K. L., T. Rhinehart-Jones, C. A. Nacy, R. K. Winegar, and A. H. Fortier. 1993 T-cell-independent resistance to infection and generation of immunity to Francisella tularensis Infect. Immun. 61 823–829
Elkins, K. L., T. R. Rhinehart-Jones, S. J. Culkin, D. Yee, and R. K. Winegar. 1996 Minimal requirements for murine resistance to infection with Francisella tularensis LVS Infect. Immun. 64 3288–3293
Elkins, K. L., A. T. MacIntyre, and T. R. Rhinehart-Jones. 1998 Nonspecific early protective immunity in Francisella and Listeria infections can be dependent on lymphocytes Infect. Immun. 66 3467–3469
Elkins, K. L., C. M. Bosio, and T. R. Rhinehart-Jones. 1999a Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the model intracellular bacterium, Francisella tularensis LVS Infect. Immun 67 in press–
Elkins, K. L., T. R. Rhinehart-Jones, C. Stibitz, J. S. Conover, and D. M. Klinman. 1999b Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria J. Immunol. 162 2291–2298
Ericsson, M., G. Sandström, A. Sjöstedt, and A. Tärnvik. 1994 Persistance of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection J. Infect. Dis. 170 110–114
Forsman, M., G. Sandström, and B. Jaurin. 1990 Identification of Francisella species and discrimination of type A and type B strains of F. tularensis by 16S RNA analysis Appl. Environ. Microbiol. 56 949–955
Forsman, M., G. Sandström, and A. Sjöstedt. 1994 Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR Internatl. J. System. Bacteriol. 44 38–46
Fortier, A. H., M. V. Slayter, R. Ziemba, M. S. Meltzer, and C. A. Nacy. 1991 Live vaccine strain of Francisella tularensis: infection and immunity in mice Infect. Immun. 59 2922–2928
Fortier, A. H., T. Polsinelli, S. J. Green, and C. A. Nacy. 1992 Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules Infect. Immun. 60 817–825
Fortier, A. H., D. A. Leiby, R. B. Narayanan, E. Asafoadjei, R. M. Crawford, C. A. Nacy, and M. S. Meltzer. 1995 Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth Infect. Immun. 63 1478–1483
Foshay, L. 1950 Tularaemia Ann. Rev. Microbiol. 4 313–330
Francis, E. 1925 Tularemia JAMA 84 1243–1250
Francis, E. 1928 A summary of the present knowledge of tularemia Medicine 7 411–426
Fulop, M., D. Leslie, and R. Titball. 1996 A rapid, highly sensitive method for the detection of Francisella tularensis in clinical samples using the polymerase chain reaction Am. J. Trop. Med. Hyg. 54 364–366
Garrett, T. A., J. L. Kadrmas, and C. R. H. Raetz. 1997 Identification of the gene encoding the Escherichia coli lipid A 4’-kinase J. Biol. Chem. 272 21855–21864
Golovliov, I., G. Sandström, M. Ericsson, A. Sjöstedt, and A. Tärnvik. 1995 Cytokine expression in the liver during the early phase of murine tularemia Infect. Immun. 63 534–538
Golovliov, I., K. Kuoppa, A. Sjöstedt, A. Tärnvik, and G. Sanström. 1996 Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis FEMS Immunol. Med. Microl 13 239–244
Golovliov, I., M. Ericsson, G. Sandström, A. Tärnvik, and A. Sjöstedt. 1997 Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein Infect. Immun. 65 2183–2189
Green, S. J., C. A. Nacy, R. D. Schreiber, D. L. Granger, R. M. Crawford, M. S. Meltzer, and A. H. Fortier. 1993 Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice Infect. Immun. 61 689–698
Haas, R., A. F. Kahrs, D. Facius, H. Allmeier, R. Schmitt, and T. F. Meyer. 1993 TnMax-a versatile mini-transposon for the analysis of cloned genes and shuttle mutagenesis Gene 130 23–31
Hambleton, P., C. G. T. Evans, A. M. Hood, and R. E. Strange. 1974 Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components Br. J. Exp. Path. 55 363–373
Hollis, D. G., R. E. Weaver, A. G. Steigerwalt, J. D. Wenger, C. W. Moss, and D. J. Brenner. 1989 Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease J. Clin. Microbiol. 27 1601–1608
Hood, A. M. 1977 Virulence factors of Francisella tularensis J. Hyg. 79 47–65
Hornick, R. B., and H. T. Eigelsbach. 1969 Tularemia epidemic—Vermont, 1968 N. Engl. J. Med. 281 1310
Janeway, C. A., Jr. 1992 The immune system evolved to discriminate infectious nonself from noninfectious self Immunol. Today 13 11–16
Jantzen, E., B. P. Berdal, and T. Omland. 1979 Cellular fatty acid composition of Francisella tularensis J. Clin. Microbiol. 10 928–930
Jensen, W. I., D. R. Owen, and W. J. Jellison. 1969 Yersinia philomirogia sp. n., a new member of the Pasteurella group of bacteria, naturally pathogenic for the muskrat (Ondatra zibethica) J. Bacteriol. 100 1237–1241
Karttunen, R., G. Andersson, H.-P. T. Ekre, K. Juutinen, H.-M. Surcel, H. Syrjala, and E. Herva. 1987 Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination J. Clin. Micro. 25 1074–1078
Karttunen, R., H.-M. Surcel, G. Andersson, H.-P. T. Ekre, and E. Herva. 1991 Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings J. Clin. Micro. 29 753–756
Kaufmann, S. H. E., H.-R. Rodewald, E. Hug, and G. DeLibero. 1988 Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity J. Immunol. 140 3173–3179
Koskela, P., and E. Herva. 1980 Cell-mediated immunity against Francisella tularensis after natural infection. Scand J. Infect. Dis. 12 281–287
Koskela, P., and E. Herva. 1982 Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine Infect. Immun. 36 983–989
Koskela, P., and A. Salminen. 1985 Humoral immunity against Francisella tularensis after natural infection J. Clin. Micro. 22 973–979
Larson, C. L., W. Wicht, and W. L. Jellison. 1955 An organism resembling P. tularensis from water Public Health Rep. 70 253–258
Leiby, D. A., A. H. Fortier, R. M. Crawford, R. D. Schreiber, and C. A. Nacy. 1992 In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies Infect. Immun. 60 84–89
Löfgren, S., A. Tärnvik, G. D. Bloom, and W. Sjöberg. 1983 Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes Infect. Immun. 39 715–720
Long, G. W., J. J. Oprandy, R. B. Narayanan, A. H. Fortier, K. R. Porter, and C. A. Nacy. 1993 Detection of Francisella tularensis in blood by polymerase chain reaction J. Clin. Microbiol. 31 152–154
McCoy, G. W., and C. W. Chapin. 1912 Further observations on a plague like disease of rodents with a preliminary note on the causative agent bacterium tularense J. Infect. Dis. 10 61–72
McCrumb, F. R. 1961 Aerosol infection of man with Pasteurella tularensis Bact. Rev. 25 262–267
McDonald, M. K., S. C. Cowley, and F. E. Nano. 1997 Temperature-sensitive lesions in the Francisella novicida valA gene cloned into an Escherichia coli msbA lpxK mutant affecting deoxycholate resistance and lipopolysaccharide assembly at the restrictive temperature J. Bacteriol. 179 7638–7643
Mdluli, K. E., L. S. D. Anthony, G. S. Baron, M. K. McDonald, S. V. Myltseva, and F. E. Nano. 1994 Serum sensitive mutation of Francisella novicida: association with an ABC transporter protein Microbiol. 140 3309–3318
Mokreivich, A. N., V. V. Fursov, and V. M. Pavlov. 1994 Plasmid cryotransformation Problemy Osobo Opasnyh Infecktsy Saratov 4 186–190
Niebylski, M. L., M. G. Peacock, E. R. Fischer, S. F. Porcella, and T. G. Schwan. 1997 Characterization of an endosymbiont infecting wood ticks, Dermacentor andersoni, as a member of the genus Francisella Appl. Environ. Microbiol. 63 3933–3940
Noda, H., U. G. Munderloh, and T. J. Kurtti. 1997 Endosymbionts of ticks and their relationship to Wolbachia spp. and tick-borne pathogens of humans and animals Appl. Environ. Microbiol. 63 3926–3932
Norqvist, A., K. Kuoppa, and G. Sandström. 1996 Construction of a shuttle vector for use in Francisella tularensis FEMS Immunol. Med. Microbiol. 13 257–260
Ohara, S. 1954 Studies on Yato-Byo (Ohara’s disease, tularemia in Japan), report I Jpn. J. Exp. Med. 24 69–85
Overholt, E. L., W. D. Tigertt, P. J. Kadull, M. K. Ward, N. D. Charkes, R. M. Rene, T. E. Salzman, and S. Mallory. 1961 An anlysis of forty-two cases of laboratory-acquired tularemia: treatment with broad-spectrum antibiotics Am. J. Med. Sci. 30 785–791
Owen, C. R., E. O. Buker, W. L. Jellison, D. B. Lackman, and J. F. Bell. 1964 Comparative studies of Francisella tularensis and Francisella novicida J. Bacteriol. 87 676–683
Pavlov, V. M., A. N. Mokrievich, and K. Volkovo. 1996 Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis FEMS Immunol.Med.Microbiol. 13 253–256
Polsinelli, T., M. S. Meltzer, and A. H. Fortier. 1994 Nitric oxide-independent killing of Francisella tularensis by IFN—stimulated murine alveolar macrophages J. Immunol. 153 1238–1245
Pomerantsev, A. P., I. V. Domaradskii, N. A. Shishkova, and Y. U. Ershov. 1991 Behavior of the Sa plasmid in cells of the tularemia microbe Molekul. Genet. Mikrobiol. Virusol 9 17–21
Poquet, Y., M. Kroca, F. Halary, S. Stenmark, M. A. Peyrat, M. Bonneville, J. J. Fournie, and A. Sjöstedt. 1998 Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination Infect. Immun. 66(5): 2107–2114
Reilly, T. J. G., S. Baron, F. E. Nano, and M. S. Kuhlenschmidt. 1996 Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis J. Biol. Chem. 271 10973–10983
Rhinehart-Jones, T. R., A. H. Fortier, and K. L. Elkins. 1994 Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells Infect. Immun. 62 3129–3137
Sandström, G., A. Tärnvik, and H. Wolf-Watz. 1987 Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis J. Clin. Micro. 25 641–644
Sandström, G., S. Löfgren, and A. Tärnvik. 1988 A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes Infect. Immun. 56 1194–1202
Sandström, G., A. Sjöstedt, T. Johansson, K. Kuoppa, and J. C. Williams. 1992 Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS FEMS Microbiol. Immunol. 105 201–210
Sandström, G. 1994 The tularemia vaccine J. Chem. Tech. Biotechnol. 59 315–320
Sanford, J. P. 1983 Tularemia JAMA 250 3225–3226
Schricker, R. L., H. T. Eigelsbach, J. Q. Mitten, and W. C. Hall. 1972 Pathogenesis of tularemia in monkeys aerogenically exposed to Francisella tularensis 425 Infect. Immun. 5 734–744
Sicherer, S. H., E. G. Asturias, J. A. Winkelstein, J. D. Dick, and R. E. Willoughby. 1997 Francisella philomiragia sepsis in chronic granulomatous disease Pediatr. Infect. Dis. J. 16 420–422
Sjöstedt, A., G. Sandström, and A. Tärnvik. 1990 Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals J. Clin. Micro. 28 43–48
Sjöstedt, A., G. Sandström, A. Tärnvik, and B. Jaurin. 1989 Molecular cloning and expression of a T-cell stimulating membrane protein of Francisella tularensis Microb. Path. 6 403–414
Sjöstedt, A., J. W. Conlan, and R. J. North. 1994 Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection Infect. Immun. 62 2779–2783
Sjöstedt, A., K. Kuoppa, T. Johansson, and G. Sandström. 1992b The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis Microb. Path. 13 243–249
Sjöstedt, A., M. Eriksson, G. Sanström, and A. Tärnvik. 1992a Various membrane proteins of Francisella tularensis induce interferon—production in both CD4+ and CD8+ T cells of primed humans Immunol. 76 584–592
Sumida, T., T. Maeda, H. Takahashi, S. Yoshida, F. Yonaha, A. Sakamoto, H. Tomioka, T. Koike, and S. Yoshida. 1992 Predominant expansion of V?9/V?2 T cells in a tularemia patient Infect. Immun. 60 2554–2558
Surcel, H. M., S. Tapaninaho, and E. Herva. 1991b Cytotoxic CD4+ T cells specific for Francisella tularensis Clin. Exp. Immunol. 83 112–115
Surcel, H.-M., H. Syrjälä, R. Karttunen, S. Tapaninaho, and E. Herva. 1991a Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and-4) during human tularemia Infect. Immun. 59 1948–1953
Surcel, H.-M., M. Sarvas, I. M. Helander, and E. Herva. 1989 Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals Microb. Path. 7 411–419
Surcel, H.-M. 1990 Diversity of Francisella tularensis antigens recognized by human T lymphocytes Infect. Immun. 58 2664–2668
Tärnvik, A., and S. E. Holm. 1978 Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis Infect. Immun. 20 698–704
Tärnvik, A., and S. Löfgren. 1975 Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis Infect. Immun. 12 951–957
Tärnvik, A., M. Eriksson, G. Sandström, and A. Sjöstedt. 1992 Francisella tularensis-a model for studies of the immune response to intracellular bacteria in man Immunol. 76 349–354
Tärnvik, A. 1989 Nature of protective immunity to Francisella tularensis Rev. Infect. Dis. 11 440–451
Teutsch, S. M., W. J. Martone, E. W. Brink, M. E. Potter, G. Eliot, R. Hoxsie, R. B. Craven, and A. F. Kaufmann. 1979 Pneumonic tularemia on Martha’s Vineyard N. Engl. J. Med. 301 826–828
Thorpe, B. D., and S. Marcus. 1965 Phagocytosis and intracellular fate of Pasteurella tularensis. III. In vivo studies with passively transferred cells and sera J. Immunol. 94 578–585
Tigertt, W. D. 1962 Soviet viable Pasteurella tularensis vaccines. A review of selected articles Bact. Rev 26 354–373
Tyeryar, F. J. Jr., and W. D. Lawton. 1970a Transformation of Pasteurella novicida J. Bacteriol. 100:2 1112–1113
Tyeryar, F. J. Jr., and W. D. Lawton. 1970b Factors affecting transformation of Pasteurella novicida J. Bacteriol. 104 1312–1317
Viljanen, M. K., T. Nurmi, and A. Salminen. 1983 Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen J. Infect. Dis. 148 715–720
Waag, D. M., K. T. McKee Jr., G. Sandstrom, L. L. K. Pratt, C. R. Bolt, M. J. England, G. O. Nelson, and J. C. Williams. 1995 Cell-mediated and humoral immune responses after vaccination of human volunteers with the Live Vaccine Strain Clin. Diagn. Lab. Immunol. 2 143–148
Wenger, J. D., D. G. Hollis, R. E. Weaver, C. N. Baker, G. R. Brown, D. J. Brenner, and C. V. Broome. 1989 Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen Ann. Int. Med. 110 888–892
White, J. D., J. R. Rooney, P. A. Prickett, E. B. Derrenbacher, C. W. Beard, and W. R. Griffith. 1964 Pathogenesis of experimental respiratory tularemia in monkeys J. Infect. Dis. 114 277–283
Wood, J. B., K. Valteris, and R. H. Hardy. 1976 Imported tularaemia Br. Med. J. 76 811–812
Yee, D., T. R. Rhinehart-Jones, and K. L. Elkins. 1996 Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS J. Immunol. 157 5042–5048
Young, L. S., D. S. Bicknell, B. G. Archer, J. M. Clinton, L. J. Leavens, J. C. Feeley, and P. S. Brachman. 1969 Tularemia epidemic: Vermont, 1968 N. Engl. J. Med. 280 1253–1260
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag
About this entry
Cite this entry
Nano, F., Elkins, K. (2006). The Genus Francisella. In: Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, KH., Stackebrandt, E. (eds) The Prokaryotes. Springer, New York, NY. https://doi.org/10.1007/0-387-30746-X_44
Download citation
DOI: https://doi.org/10.1007/0-387-30746-X_44
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-25496-8
Online ISBN: 978-0-387-30746-6
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences